Total Revenue

(In Billions)

$60.7
2011
$61.5
2012
$71.0
2013
$73.9
2014
$79.2
2015

Benefit Expense Ratio

 

85.1%
2011
85.3%
2012
85.1%
2013
83.1%
2014
83.3%
2015

Selling, General and Administrative Expense Ratio

14.1%
2011
14.3%
2012
14.2%
2013
16.1%
2014
16.0%
2015

Diluted Net Income Per Share

(In Whole Dollars)

$7.25
2011
$8.18
2012
$8.20
2013
$8.99
2014
$9.38
2015
2015 Medical
Membership
  • 19% National Accounts
  • 14% BlueCard®
  • 4% Medicare
  • 15% Medicaid
  • 4% Federal Employee Health Benefits
  • 40% Local Group
  • 4% Individual

Customer Base

  • 39% Fully-Insured
  • 61% Self-Funded

Total Medical Membership

(In Millions)

34.3
2011
36.1
2012
35.7
2013
37.5
2014
38.6
2015

The information presented below is as reported in anthem’s 2015 annual report on form 10-k.

(Dollars in millions, except per share data) 2015 2014 2013
Operating Results
Total operating revenue $78,404.8 $73,021.7 $70,191.4
Total revenue 79,156.5 73,874.1 71,023.5
Net income 2,560.0 2,569.7 2,489.7
Earnings Per Share      
Basic net income $9.73 $9.31 $8.34
Diluted net income 9.38 8.99 8.20
Dividends per share (in whole dollars) 2.50 1.75 1.50
Balance Sheet Information      
Total assets $61,717.8 $61,676.3 $59,095.3
Total liabilities 38,673.7 37,425.0 34,330.1
Total shareholders’ equity 23,044.1 24,251.3 24,765.2
Medical Membership (in thousands)
Commercial and Specialty Business 29,678 29,364 28,307
Government Business 8,921 8,135 7,346
Total Medical Membership 38,599 37,499 35,653
Customer Type      
Local Group 15,241 15,137 14,725
Individual 1,675 1,793 1,755
National:      
National Accounts 7,355 7,155 6,777
BlueCard® 5,407 5,279 5,050
Total National 12,762 12,434 11,827
Medicare 1,439 1,404 1,441
Medicaid 5,914 5,193 4,378
FEP 1,568 1,538 1,527
Total Medical Membership by Customer Type 38,599 37,499 35,653
Funding Arrangement      
Self-Funded 23,666 22,800 20,294
Fully-Insured 14,933 14,699 15,359
Total Medical Membership by Funding Arrangement 38,599 37,499 35,653
Other Membership      
Life and Disability Members 4,849 4,762 4,819
Dental Members 5,206 4,995 4,895
Dental Administration Members 5,282 4,918 4,886
Vision Members 5,641 5,096 4,743
Medicare Advantage Part D Members 622 690 628
Medicare Part D Standalone Members 371 467 474
(Dollars in millions, except share data) December 31,
2015
December 31,
2014
Assets
Current assets:    
Cash and cash equivalents $2,113.5 $2,151.7
Investments available-for-sale, at fair value:    
Fixed maturity securities (amortized cost of $16,950.0 and $17,120.4) 16,920.0 17,467.4
Equity securities (cost of $1,055.8 and $1,303.7) 1,441.8 1,906.6
Other invested assets, current 19.1 20.2
Accrued investment income 170.8 161.4
Premium and self-funded receivables 4,602.8 4,825.5
Other receivables 2,421.4 2,117.0
Income taxes receivable 316.6 308.9
Securities lending collateral 1,300.4 1,515.2
Other current assets 1,555.7 1,473.9
Total current assets 30,862.1 31,947.8
Long-term investments available-for-sale, at fair value:    
Fixed maturity securities (amortized cost of $550.4 and $500.7) 558.2 504.4
Equity securities (cost of $27.3 and $27.0) 31.0 31.5
Other invested assets, long-term 2,041.1 1,695.9
Property and equipment, net 2,019.8 1,944.3
Goodwill 17,562.2 17,082.0
Other intangible assets 8,158.0 7,958.1
Other noncurrent assets 485.4 512.3
Total assets $61,717.8 $61,676.3
Liabilities and shareholders’ equity
Liabilities    
Current liabilities:    
Policy liabilities:    
Medical claims payable $7,569.8 $6,861.2
Reserves for future policy benefits 71.9 68.1
Other policyholder liabilities 2,256.5 2,626.5
Total policy liabilities 9,898.2 9,555.8
Unearned income 1,145.5 1,078.1
Accounts payable and accrued expenses 3,318.8 3,651.8
Security trades pending payable 73.1 66.2
Securities lending payable 1,300.9 1,515.3
Short-term borrowings 540.0 400.0
Current portion of long-term debt 624.3
Other current liabilities 2,816.1 1,861.2
Total current liabilities 19,092.6 18,752.7
Long-term debt, less current portion 15,324.5 14,019.6
Reserves for future policy benefits, noncurrent 631.7 671.3
Deferred tax liabilities, net 2,630.6 2,945.6
Other noncurrent liabilities 994.3 1,035.8
Total liabilities 38,673.7 37,425.0
Commitments and contingencies—Note 13 included in 2015 Annual Report on form 10-K    
Shareholders’ equity    
Preferred stock, without par value, shares authorized—100,000,000; shares issued and outstanding—none
Common stock, par value $0.01, shares authorized—900,000,000; shares issued and outstanding—261,238,188 and 268,109,932 2.6 2.7
Additional paid-in capital 8,555.6 10,062.3
Retained earnings 14,778.5 14,014.4
Accumulated other comprehensive (loss) income (292.6) 171.9
Total shareholders’ equity 23,044.1 24,251.3
Total liabilities and shareholders’ equity $61,717.8 $61,676.3

Note 1: The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in Anthem’s 2015 Annual Report on Form 10-K.

Note 2: Certain prior year amounts have been reclassified to conform to current year presentation.

  Years Ended December 31
(Dollars in millions, except per share data) 2015 2014 2013
Revenues
Premiums $73,385.1 $68,389.8 $66,119.1
Administrative fees 4,976.6 4,590.6 4,031.9
Other revenue 43.1 41.3 40.4
Total operating revenue 78,404.8 73,021.7 70,191.4
Net investment income 677.6 724.4 659.1
Net realized gains on investments 157.5 177.0 271.9
Other-than-temporary impairment losses on investments:
Total other-than-temporary impairment losses on investments (99.9) (56.2) (100.6)
Portion of other-than-temporary impairment losses recognized in other comprehensive income 16.5 7.2 1.7
Other-than-temporary impairment losses recognized in income (83.4) (49.0) (98.9)
Total revenues 79,156.5 73,874.1 71,023.5
Expenses
Benefit expense 61,116.9 56,854.9 56,237.1
Selling, general and administrative expense:
Selling expense 1,441.1 1,490.1 1,526.9
General and administrative expense 11,093.7 10,258.3 8,426.0
Total selling, general and administrative expense 12,534.8 11,748.4 9,952.9
Interest expense 653.0 600.7 602.7
Amortization of other intangible assets 230.1 220.9 245.3
(Gain) loss on extinguishment of debt (9.3) 81.1 145.3
Total expenses 74,525.5 69,506.0 67,183.3
Income from continuing operations before income tax expense 4,631.0 4,368.1 3,840.2
Income tax expense 2,071.0 1,808.0 1,205.9
Income from continuing operations 2,560.0 2,560.1 2,634.3
Income (loss) from discontinued operations, net of tax 9.6 (144.6)
Net income $2,560.0 $2,569.7 $2,489.7
Basic net income (loss) per share:      
Basic—continuing operations $9.73 $9.28 $8.83
Basic—discontinued operations 0.03 (0.49)
Basic net income per share $9.73 $9.31 $8.34
Diluted net income (loss) per share:      
Diluted—continuing operations $9.38 $8.96 $8.67
Diluted—discontinued operations 0.03 (0.47)
Diluted net income per share $9.38 $8.99 $8.20
Dividends per share $2.50 $1.75 $1.50

The information presented above should be read in conjunction with the audited consolidated financial statements and accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in Anthem’s 2015 Annual Report on Form 10-K.

  Years Ended December 31
(Dollars in millions) 2015 2014 2013
Net income $2,560.0 $2,569.7 $2,489.7
Other comprehensive (loss) income, net of tax:      
Change in net unrealized gains/losses on investments (384.3) 118.6 (294.7)
Change in non-credit component of other-than-temporary impairment losses on investments (5.6) (3.9) 1.7
Change in net unrealized gains/losses on cash flow hedges (45.2) (3.6) 3.0
Change in net periodic pension and postretirement costs (26.0) (118.1) 172.7
Foreign currency translation adjustments (3.4) (4.3) 1.4
Other comprehensive loss (464.5) (11.3) (115.9)
Total comprehensive income $2,095.5 $2,558.4 $2,373.8

The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in Anthem’s 2015 Annual Report on Form 10-K.

  Years Ended December 31
(Dollars in millions) 2015 2014 2013
Operating activities
Net income $2,560.0 $2,569.7 $2,489.7
Adjustments to reconcile net income to net cash provided by
operating activities:
     
Net realized gains on investments (157.5) (177.0) (271.9)
Other-than-temporary impairment losses recognized in income 83.4 49.0 98.9
(Gain) loss on extinguishment of debt (9.3) 81.1 145.3
(Gain) loss on disposal from discontinued operations (3.2) 221.8
Loss (gain) on disposal of assets 16.0 (1.7) 3.9
Deferred income taxes (65.9) 30.7 59.1
Amortization, net of accretion 802.1 744.5 800.9
Depreciation expense 105.8 106.5 107.9
Impairment of property and equipment 1.8 7.9 47.7
Share-based compensation 148.2 168.9 146.0
Excess tax benefits from share-based compensation (95.8) (46.4) (30.1)
Changes in operating assets and liabilities:      
Receivables, net (42.9) (1,899.7) 418.3
Other invested assets 5.9 (21.7) (15.1)
Other assets 33.8 405.5 (33.6)
Policy liabilities 193.0 1,240.6 (345.8)
Unearned income 33.9 255.1 (73.8)
Accounts payable and accrued expenses (219.3) (14.4) 303.6
Other liabilities 686.4 (7.9) (154.6)
Income taxes 41.5 (34.0) 9.3
Other, net (5.1) (84.2) (38.6)
Net cash provided by operating activities 4,116.0 3,369.3 3,052.3
Investing activities
Purchases of fixed maturity securities (9,792.0) (9,613.4) (13,704.5)
Proceeds from fixed maturity securities:      
Sales 8,909.2 8,066.0 10,977.9
Maturities, calls and redemptions 1,313.6 1,318.7 1,836.8
Purchases of equity securities (1,561.4) (912.0) (820.3)
Proceeds from sales of equity securities 1,471.1 746.5 721.0
Purchases of other invested assets (505.8) (205.7) (251.5)
Proceeds from sales of other invested assets 85.9 124.7 127.1
Settlement of non-hedging derivatives (36.5) (67.4) (109.8)
Changes in securities lending collateral 214.4 (545.6) (405.1)
Purchases of subsidiaries, net of cash acquired (638.9)
Proceeds from sale of subsidiary, net of cash sold 740.0
Purchases of property and equipment (638.2) (714.6) (646.5)
Proceeds from sales of property and equipment 35.3 88.0 39.2
Other, net (8.2) (0.1) 1.3
Net cash used in investing activities (1,151.5) (974.9) (2,234.4)
Financing activities
Net proceeds from (repayments of) commercial paper borrowings 682.2 (379.2) (191.7)
Proceeds from long-term borrowings 1,226.5 2,700.0 1,250.0
Repayments of long-term borrowings (2,697.2) (1,730.1) (1,801.9)
Proceeds from short-term borrowings 2,760.0 2,050.0 1,100.0
Repayments of short-term borrowings (2,620.0) (2,050.0) (950.0)
Changes in securities lending payable (214.4) 545.6 405.0
Changes in bank overdrafts (243.8) 173.0 9.9
Premiums paid on equity call options (16.7) (25.8)
Proceeds from sale of put options 16.6
Repurchase and retirement of common stock (1,515.8) (2,998.8) (1,620.1)
Cash dividends (656.6) (480.7) (448.0)
Proceeds from issuance of common stock under employee
stock plans
186.0 301.3 524.7
Excess tax benefits from share-based compensation 95.8 46.4 30.1
Net cash used in financing activities (2,997.4) (1,822.5) (1,717.8)
Effect of foreign exchange rates on cash and cash equivalents (5.3) (7.1) 2.2
Change in cash and cash equivalents (38.2) 564.8 (897.7)
Cash and cash equivalents at beginning of year 2,151.7 1,586.9 2,484.6
Cash and cash equivalents at end of year 2,113.5 2,151.7 1,586.9
Less cash and cash equivalents of discontinued operations at end of year (4.8)
Cash and cash equivalents of continuing operations at end of year $2,113.5 $2,151.7 $1,582.1

The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in Anthem’s 2015 Annual Report on Form 10-K.

Our common stock, par value $0.01 per share, is listed on the NYSE under the symbol “ANTM.” On February 4, 2016, the closing price on the NYSE was $126.64. As of February 4, 2016, there were 71,430 shareholders of record of our common stock. The following table presents high and low sales prices for our common stock on the NYSE for the periods indicated.

 
  High Low
2015
First Quarter $160.64 $122.86
Second Quarter 173.59 148.29
Third Quarter 165.93 134.62
Fourth Quarter 149.87 126.25
2014
First Quarter $102.56 $81.84
Second Quarter 110.03 90.75
Third Quarter 124.58 106.52
Fourth Quarter 129.96 108.92